About PregLem
PregLem is a company based in Geneve (Switzerland) founded in 2006 was acquired by Gedeon Richter in October 2010.. PregLem has raised $57.94 million across 2 funding rounds from investors including MVM Partners, Sofinnova and NeoMed. PregLem operates in a competitive market with competitors including Sprout Pharmaceuticals, Hope Medicine, Rejoni, ObsEva and Gameto, among others.
- Headquarter Geneve, Switzerland
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$57.94 M (USD)
in 2 rounds
-
Latest Funding Round
$31.89 M (USD), Series B
Dec 04, 2007
-
Investors
MVM Partners
& 4 more
-
Employee Count
Employee Count
-
Acquired by
Gedeon Richter
(Oct 07, 2010)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of PregLem
PregLem has successfully raised a total of $57.94M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $31.89 million completed in December 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $31.9M
-
First Round
First Round
(27 Jun 2007)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2007 | Amount | Series B - PregLem | Valuation | Sofinnova Investments | |
| Jun, 2007 | Amount | Series A - PregLem | Valuation | NeoMed , MVM |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PregLem
PregLem has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include MVM Partners, Sofinnova and NeoMed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech funding, drug development support, and investment in life sciences.
|
Founded Year | Domain | Location | |
|
Private equity investments in healthcare companies are managed.
|
Founded Year | Domain | Location | |
|
Stage-agnostic life sciences-focused VC firm investing in North America & Europe
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PregLem
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PregLem
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Preglem Comparisons
Competitors of PregLem
PregLem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sprout Pharmaceuticals, Hope Medicine, Rejoni, ObsEva and Gameto, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drugs for hypoactive sexual desire disorder in women are developed.
|
|
| domain | founded_year | HQ Location |
Monoclonal antibodies are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for women's health conditions are developed using innovative hydrogels.
|
|
| domain | founded_year | HQ Location |
Therapeutics for women's reproductive health and pregnancy are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for fertility and menopause treatments are developed.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for reproductive health are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about PregLem
When was PregLem founded?
PregLem was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Where is PregLem located?
PregLem is headquartered in Geneve, Switzerland. It is registered at Geneve, Geneve, Switzerland.
Is PregLem a funded company?
PregLem is a funded company, having raised a total of $57.94M across 2 funding rounds to date. The company's 1st funding round was a Series A of $26.05M, raised on Jun 27, 2007.
What does PregLem do?
PregLem is dedicated to the development and commercialization of innovative drugs for womens reproductive medicine. It markets ESMYA (ulipristal acetate), an oral selective progesterone receptor modulator (SPRM) for long-term management of uterine fibroids. Its drug pipeline includes PGL2001, an oral, once-a-week steroid sulfatase inhibitor (STS-I) being developed for the management of endometriosis, including the relief of pain associated with the condition (Phase 2a); PGL1001, a somatostatin antagonist (SST-ATG) with the potential to accelerate the recruitment of resting follicles from the ovarian follicular reserve (preclinical).
Who are the top competitors of PregLem?
PregLem's top competitors include Sprout Pharmaceuticals, Rejoni and Hope Medicine.
Who are PregLem's investors?
PregLem has 5 investors. Key investors include MVM Partners, Sofinnova, NeoMed, Sofinnova Partners, and Richter Gedeon.